Background: Psoriasis is a chronic, non-communicable condition of the skin with an immune-mediated etiology. Periodontitis is a chronic inflammatory disease of the tooth-supporting tissues and is now recognized as an established risk factor for various systemic diseases. The present observational study aims to assess the prevalence of periodontitis and its related indices in individuals with psoriasis and to compare them with individuals without psoriasis. A cross-sectional case-control study was performed in a hospital setting, including 200 diagnosed cases of psoriasis and 200 age- and sex-matched healthy controls.
Methods: The case group included patients diagnosed with psoriasis (defined as ICD-10 L40.0-L40.9) by a trained dermatologist. Controls included age- and sex-matched healthy individuals. After history-taking, a detailed dermatological and periodontal examination was done for all the enrolled subjects. The results were statistically analyzed using SPSS software.
Results: The study group had a significantly higher mean GI, PI, PPD and CAL in comparison to the controls. Psoriasis patients had significantly greater scores for GI and PI (1.68 ± 0.61 and 1.57 ± 0.54, respectively) as compared to controls (1.48 ± 0.56 and 1.39 ± 0.60, respectively). Periodontitis was also found to be more prevalent among the cases. Stage II and Stage III periodontitis were found in 41.0 % of cases and 30.5 % of controls, while 12.5 % of cases and 6.0 % of controls had stage IV periodontitis. This difference was statistically significant.
Conclusion: An association between psoriasis and periodontitis was found in the present study, as the individuals with psoriasis had a higher severity and prevalence of periodontitis.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11268335 | PMC |
http://dx.doi.org/10.1016/j.jobcr.2024.06.008 | DOI Listing |
Brief Bioinform
November 2024
Department of Dermatology, Daping Hospital, Army Medical University, No. 10, Changjiang Branch Road, Yuzhong District, Chongqing 400042, China.
Psoriasis affects a significant proportion of the worldwide population and causes an extremely heavy psychological and physical burden. The existing therapeutic schemes have many deficiencies such as limited efficacies and various side effects. Therefore, novel ways of treating psoriasis are urgently needed.
View Article and Find Full Text PDFRheumatol Int
January 2025
Department of Rheumatology, Guy's Hospital, Great Maze Pond, London, SE1 9RT, UK.
This systematic review aims to summarise the association between skin disease and quality of life (QoL) in people with psoriatic arthritis (PsA) and identify areas for future research and management. This review was registered on PROSPERO (CRD42024500994). Databases were searched for articles in English published until 7th January 2025.
View Article and Find Full Text PDFFront Immunol
January 2025
Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Institue of Psoriasis, Tongji University School of Medicine, Shanghai, China.
Background: Acrodermatitis continua of Hallopeau (ACH) is a rare, sterile pustular psoriasis variant refractory to many conventional treatments. The eruption typically occurs after local trauma or infection; other etiologies include neural, inflammatory, and genetic causes. Herein we reported a single case of a 64-year-old patient with ACH that was successfully treated with spesolimab for 19 weeks.
View Article and Find Full Text PDFEur J Med Res
January 2025
The Department of Pediatrics, The Third Xiangya Hospital of Central South University, Changsha, 410013, Hunan, China.
Background: The systemic immune-inflammation index (SII) is an emerging marker of inflammation, and the onset of psoriasis is associated with inflammation. The aim of our study was to investigate the potential impact of SII on the incidence rate of adult psoriasis.
Methods: We conducted a cross-sectional study based on the National Health and Nutrition Examination Survey (NHANES) 2011-2014 data sets.
JMIR Res Protoc
January 2025
Department of Dermatology, Hospital Universitario Ramon y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain, Madrid, Spain.
Background: Psoriasis is an inflammatory disease primarily treated through molecular-targeted therapies. However, emerging evidence suggests that dietary interventions may also play a role in managing inflammation associated with this condition. The Mediterranean diet (MedDiet), prevalent in southern European countries, has been widely recognized for its ability to reduce cardiovascular mortality, largely due to its anti-inflammatory properties.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!